Drug Infusion System Flaw Could Lead to Attack

November 17, 2020

Manufacturer BD and CISA Issue Warnings

Drug Infusion System Flaw Could Lead to Attack

Medical device maker Becton Dickinson and federal authorities have issued alerts concerning an authentication weakness that, if exploited, could result in a denial-of-service attack on certain models of the BD Alaris PC Unit drug infusion and monitoring system.

Carrie Whysall, Director of Managed Security Services at CynergisTek, offered commentary for this article, which covers hospitals dealing with COVID-19 cases, having to resort to manual operation of any medical devices which could potentially result in delays and disruptions to patient care.

Click here to read the full story.

Previous Article
Digital Transformation Can Help Healthcare Organizations Struggling In A Pandemic
Digital Transformation Can Help Healthcare Organizations Struggling In A Pandemic

This article covers the need for digital transformation in healthcare organizations since the pandemic bega...

Next Article
Breach Lawsuit Spotlights Complex Vendor Issues
Breach Lawsuit Spotlights Complex Vendor Issues

Marti Arvin offered commentary for this article, which covers the lawsuit filed by Zoll Medical against IT ...